Patents by Inventor D. John Faulkner

D. John Faulkner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6300371
    Abstract: A diterpene derivative compound, having the formula I, II, or III, compositions, and therapeutic compositions containing the compounds are disclosed. Also disclosed are methods for treating an inflammatory disorder by providing an inflammatory inhibiting amount of the compound as well as methods for obtaining the compound.
    Type: Grant
    Filed: April 16, 1999
    Date of Patent: October 9, 2001
    Assignees: Indian Institute of Chemical Technology, University of California
    Inventors: D. John Faulkner, Y. Venkateswarlu, K. V. Raghavan, J. S. Yadav
  • Patent number: 4952605
    Abstract: Analogs of the marine natural product manoalide are useful in treating mammals, including humans, in need of a drug having analgesic/anti-inflammatory, immunosuppressive, and/or antiproliferative activity.
    Type: Grant
    Filed: November 18, 1988
    Date of Patent: August 28, 1990
    Assignee: The Regents of the University of California
    Inventors: Robert S. Jacobs, D. John Faulkner
  • Patent number: 4789749
    Abstract: Analogs of the marine natural product manoalide are useful in treating mammals, including humans, in need of a drug having analgesic/anti-inflammatory, immunosuppressive, and/or antiproliferative activity.
    Type: Grant
    Filed: February 19, 1986
    Date of Patent: December 6, 1988
    Assignee: The Regents of the University of California
    Inventors: Robert S. Jacobs, D. John Faulkner
  • Patent number: 4616089
    Abstract: Synthetic analogs of the marine natural product manoalide include 3,7-Bis(hydroxymethyl)-4-hydroxy-11-methyl-13-(2',6',6'-trimethylcyclohexe nyl)-2,6,10-tridecatrienoic acid .gamma.-lactone, manoalide .delta.-lactone, manoalide .delta.-lactone acetate and dehydro-seco-manoalide.The method of treating mammals including humans in need of a drug having analgesic and/or anti-inflammatory activity comprising the administration of a therapeutically effective amount of a synthetic analog of manoalide.
    Type: Grant
    Filed: June 18, 1984
    Date of Patent: October 7, 1986
    Assignee: University of California
    Inventors: Robert S. Jacobs, D. John Faulkner
  • Patent number: 4447445
    Abstract: The method of treating mammals including humans in need of a drug having analgesic and/or anti-inflammatory activity comprising the administration of a therapeutically effective amount of manoalide, seco-manoalide or dehydro-seco-manoalide. The anti-inflammatory utility includes acute, chronic and delayed sensitization inflammatory processes.
    Type: Grant
    Filed: August 3, 1983
    Date of Patent: May 8, 1984
    Assignee: The Regents of the University of Calif.
    Inventors: Robert S. Jacobs, D. John Faulkner
  • Patent number: 4370484
    Abstract: A novel antimicrobial agent having the formula: ##STR1## The new antimicrobial agent may exist as the dihydrochloride salt, as shown or as tautomers of the structure, or in the form of other salts and derivatives such as amides and is normally associated with water of crystallization.The novel antimicrobial agent is obtained from Agelas sceptrum, Agelas conifera, Agelas schmidti, an unknown sponge species from Canton atoll and an unknown sponge Axinella sp., from Belize.
    Type: Grant
    Filed: March 12, 1981
    Date of Patent: January 25, 1983
    Assignee: The Regents of the University of California
    Inventor: D. John Faulkner